Paper464572
Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.
Grose WE and 2 others. Antimicrob Agents Chemother, 1979. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole. Papers, record 464572. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/464572
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sulfamethoxazole | Major topic |
| Trimethoprim | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Bacterial Infections | |
| Drug Combinations | |
| Female | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 576166 | Sulfamethoxazole-trimethoprim for infections in cancer patients. | JAMA | 1977 | https://conductscience.org/library/papers/576166 | PubMed |
| 2 | 5985268 | Potentiation of sulfonamides and antibiotics by trimethoprim [2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine]. | Antimicrob Agents Chemother (Bethesda) | 1966 | https://conductscience.org/library/papers/5985268 | PubMed |
| 3 | 4148416 | Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4148416 | PubMed |
| 4 | 4585960 | Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4585960 | PubMed |
| 5 | 4585959 | Trimethoprim-sulfamethoxazole in children: pharmacokinetics and clinical studies. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4585959 | PubMed |
| 6 | 4585951 | Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4585951 | PubMed |
| 7 | 4580950 | Trimethoprim in human saliva, bronchial secretion and lung tissue. | Acta Pharmacol Toxicol (Copenh) | 1973 | https://conductscience.org/library/papers/4580950 | PubMed |
| 8 | 4758050 | Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4758050 | PubMed |
| 9 | 4758048 | Excretion of sulfamethoxazole and trimethoprim into human bile. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4758048 | PubMed |
| 10 | 4758046 | Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4758046 | PubMed |
| 11 | 4758045 | Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4758045 | PubMed |
| 12 | 4901344 | Single-blind comparative trial of trimethoprim-sulphamethoxazole and ampicillin in the treatment of exacerbations of chronic bronchitis. | Br Med J | 1969 | https://conductscience.org/library/papers/4901344 | PubMed |
| 13 | 5301731 | Trimethoprim, a sulphonamide potentiator. | Br J Pharmacol Chemother | 1968 | https://conductscience.org/library/papers/5301731 | PubMed |
| 14 | 1039907 | Pharmacokinetics and efficacy of trimethoprim-sulfamethoxazole in the treatment of gastroenteritis in children. | Can Med Assoc J | 1975 | https://conductscience.org/library/papers/1039907 | PubMed |
| 15 | 5514974 | Pharmacokinetics of sulfamethoxazole plus trimethoprim in man and their distribution in the rat. | Chemotherapy | 1970 | https://conductscience.org/library/papers/5514974 | PubMed |
| 16 | 5361314 | Species differences among dihydrofolate reductases as a basis for chemotherapy. | Postgrad Med J | 1969 | https://conductscience.org/library/papers/5361314 | PubMed |
| 17 | 5379870 | Spectrofluorimetric method for the determination of trimethoprim in body fluids. | Chemotherapy | 1969 | https://conductscience.org/library/papers/5379870 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39148353 | Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy. | Clin Pharmacol Ther | 2025 | https://conductscience.org/library/papers/39148353 | PubMed |
| 38681899 | Lessons from Multiple Infections Such as Lymphoma Complicated with Pneumocystis Infection: A Case Report. | Infect Drug Resist | 2024 | https://conductscience.org/library/papers/38681899 | PubMed |
| 34570646 | Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an In Vitro Model of Intracellular Infection. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34570646 | PubMed |
| 34011959 | A trimethoprim derivative impedes antibiotic resistance evolution. | Nat Commun | 2021 | https://conductscience.org/library/papers/34011959 | PubMed |
| 32571820 | Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32571820 | PubMed |
| 24910807 | Cotrimoxazole - optimal dosing in the critically ill. | Ann Intensive Care | 2014 | https://conductscience.org/library/papers/24910807 | PubMed |
| 15227389 | Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions. | Tex Heart Inst J | 1990 | https://conductscience.org/library/papers/15227389 | PubMed |
| 8504623 | Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8504623 | PubMed |
| 7786002 | Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7786002 | PubMed |
| 7408366 | Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole). | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/7408366 | PubMed |
| 7387137 | Evaluation of slow infusions of co-trimoxazole by using predictive pharmacokinetics. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7387137 | PubMed |
| 7025751 | Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7025751 | PubMed |
| 6973756 | Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia. | Postgrad Med J | 1981 | https://conductscience.org/library/papers/6973756 | PubMed |
| 6759092 | Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. | Drugs | 1982 | https://conductscience.org/library/papers/6759092 | PubMed |
| 6335381 | Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6335381 | PubMed |
| 6332015 | Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy. | Eur J Clin Microbiol | 1984 | https://conductscience.org/library/papers/6332015 | PubMed |
| 3920958 | Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3920958 | PubMed |
| 3052984 | Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3052984 | PubMed |
| 2126691 | Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2126691 | PubMed |
| 525997 | Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometry. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/525997 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/464572
GET https://conductscience.org/api/papers/v1/464572/authors